163 related articles for article (PubMed ID: 16301673)
1. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis.
Salek-Ardakani S; So T; Halteman BS; Altman A; Croft M
J Immunol; 2005 Dec; 175(11):7635-41. PubMed ID: 16301673
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
[TBL] [Abstract][Full Text] [Related]
3. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
Tan SL; Zhao J; Bi C; Chen XC; Hepburn DL; Wang J; Sedgwick JD; Chintalacharuvu SR; Na S
J Immunol; 2006 Mar; 176(5):2872-9. PubMed ID: 16493044
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
5. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
8. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
9. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
[TBL] [Abstract][Full Text] [Related]
10. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.
Thakker P; Leach MW; Kuang W; Benoit SE; Leonard JP; Marusic S
J Immunol; 2007 Feb; 178(4):2589-98. PubMed ID: 17277169
[TBL] [Abstract][Full Text] [Related]
11. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
Jäger A; Dardalhon V; Sobel RA; Bettelli E; Kuchroo VK
J Immunol; 2009 Dec; 183(11):7169-77. PubMed ID: 19890056
[TBL] [Abstract][Full Text] [Related]
12. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis.
Jurynczyk M; Jurewicz A; Raine CS; Selmaj K
J Immunol; 2008 Feb; 180(4):2634-40. PubMed ID: 18250475
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
Marusic S; Leach MW; Pelker JW; Azoitei ML; Uozumi N; Cui J; Shen MW; DeClercq CM; Miyashiro JS; Carito BA; Thakker P; Simmons DL; Leonard JP; Shimizu T; Clark JD
J Exp Med; 2005 Sep; 202(6):841-51. PubMed ID: 16172261
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
16. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.
Bettelli E; Sullivan B; Szabo SJ; Sobel RA; Glimcher LH; Kuchroo VK
J Exp Med; 2004 Jul; 200(1):79-87. PubMed ID: 15238607
[TBL] [Abstract][Full Text] [Related]
17. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
18. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
Lees JR; Iwakura Y; Russell JH
J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
Natarajan C; Muthian G; Barak Y; Evans RM; Bright JJ
J Immunol; 2003 Dec; 171(11):5743-50. PubMed ID: 14634082
[TBL] [Abstract][Full Text] [Related]
20. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
